GW 841819X

CAS No. 146135-18-4

GW 841819X ( GW841819X )

Catalog No. M11985 CAS No. 146135-18-4

GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GW 841819X
  • Note
    Research use only, not for human use.
  • Brief Description
    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.
  • Description
    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain that displays activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia.
  • Synonyms
    GW841819X
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    146135-18-4
  • Formula Weight
    487.94
  • Molecular Formula
    C26H22ClN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC1=CC=CC=C1)N[C@H]2C3=NN=C(C)N3C4=CC=C(OC)C=C4C(C5=CC=C(Cl)C=C5)=N2
  • Chemical Name
    (R)-benzyl (6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)carbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chung CW, et al. J Med Chem. 2011 Jun 9;54(11):3827-38.
2. Baud MG, et al. Science. 2014 Oct 31;346(6209):638-41.
molnova catalog
related products
  • MS-417

    MS-417 (GTPL-7512) is a highly specific BET bromodomain inhibitor that binds to BRD4-BD1 and BRD4 BD2 with Kd of 36.1 uM and 25.4 uM respectively.

  • AU1

    AU1 (GSK 1379725A) is the first selective small molecule inhibitor of BPTF bromodomain (bromodomain PHD finger transcription factor) with Kd of 2.8 uM in a cell-based reporter assay.

  • PFI-3

    PFI-3 is a potent and cell active BRG/PB1 bromodomains inhibitor with Kd of 54-97 nM.